-+ 0.00%
-+ 0.00%
-+ 0.00%

Deutsche Bank Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $270

Benzinga·07/09/2026 18:56:33
Listen to the news
Deutsche Bank analyst Gregg Gilbert maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $250 to $270.